Jiangsu Hengrui – 2026Q1
The following is a summary of the financial highlights, outlook, and earnings projections for Hengrui Medicine (600276.SS) for the first quarter of 2026: Key Changes in Q1 2026 Outlook for Next Quarter EPS Forecast for the Coming Year Note: Investment forecasts involve market uncertainties (such as commercialization progress and drug review results); actual financial performance […]